CD36 and carcinoma: Gong et al. reported that the combination of upregulation of fatty acid synthase (FASN), a key enzyme in fatty acid synthesis, in CAFs, and CD36, a fatty acid transporter, in carcinoma cells enhanced the migration ability of CRC [25].